What is Avanos Medical's R&D?

Avanos Medical (AVNS) reported R&D of $5.2M in Q1 2026.

How has Avanos Medical's R&D changed year-over-year?

Avanos Medical's R&D decreased by 3.7% year-over-year, from $5.4M to $5.2M.

What is the long-term trend for Avanos Medical's R&D?

Over 4 years (2021 to 2025), Avanos Medical's R&D has grown at a -6.6% compound annual growth rate (CAGR), from $30.6M to $23.3M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Avanos Medical AVNS R&D

R&D at other companies

StrykerSYK

$413M+2.0%

Pacira BioSciences, Inc.PCRX

$28.07M+10.8%

MedtronicMDT

$671M-1.9%

IAR

Integra LifeSciencesIART

$23.5M-5.0%

Baxter InternationalBAX

$139M-0.7%

NovantaNOVT

$23.25M+0.1%

Other financials

Income statement

See full

Revenue$182.2M+8.8%

Gross profit$94.2M+4.9%

Operating income$8.9M-13.6%

Net income$5.1M-22.7%

EPS (diluted)$0.11-21.4%

Balance sheet

See full

Cash & equivalents$65.6M-32.4%

Total debt$138.4M-1.8%

Total equity$782.1M-6.8%

Total assets$1.1B-5.2%

Cash flow

See full

Operating cash flow-$12.3M-148%

CapEx$4.3M-35.8%

Free cash flow-$16.6M-187%

Valuation

See full

Market cap$1.17B+108%

Enterprise value$1.24B+105%

P/S1.6×+0.8×

Profitability

See full

Gross margin50%-4.6pp

Operating margin-9.1%-4.2pp

Net margin-10.4%-4.7pp

FCF margin1.6%-14.9pp

Returns & leverage

See full

Return on equity-9.2%-3.9pp

Debt / equity0.2×0.0×

Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avanos Medical's R&D?: Avanos Medical (AVNS) reported R&D of $5.2M in Q1 2026.
How has Avanos Medical's R&D changed year-over-year?: Avanos Medical's R&D decreased by 3.7% year-over-year, from $5.4M to $5.2M.
What is the long-term trend for Avanos Medical's R&D?: Over 4 years (2021 to 2025), Avanos Medical's R&D has grown at a -6.6% compound annual growth rate (CAGR), from $30.6M to $23.3M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.